iA Global Asset Management Inc. Decreases Position in Humana Inc. (NYSE:HUM)

iA Global Asset Management Inc. cut its stake in Humana Inc. (NYSE:HUM) by 3.1% in the second quarter, HoldingsChannel reports. The firm owned 16,015 shares of the insurance provider’s stock after selling 508 shares during the quarter. iA Global Asset Management Inc.’s holdings in Humana were worth $5,984,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Private Wealth Management Group LLC acquired a new position in shares of Humana in the 4th quarter valued at $32,000. CarsonAllaria Wealth Management Ltd. increased its position in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Family Firm Inc. purchased a new stake in shares of Humana in the 2nd quarter valued at about $37,000. Carolinas Wealth Consulting LLC boosted its position in shares of Humana by 274.1% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares during the period. Finally, Riverview Trust Co acquired a new position in Humana during the second quarter worth approximately $44,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Truist Financial raised their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Morgan Stanley assumed coverage on Humana in a research report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Oppenheimer upped their price objective on Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $396.35.

Humana Trading Up 0.9 %

NYSE HUM opened at $354.47 on Friday. The firm has a market capitalization of $42.71 billion, a price-to-earnings ratio of 22.07, a PEG ratio of 2.09 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.67 and a current ratio of 1.66. Humana Inc. has a one year low of $298.61 and a one year high of $530.54. The company’s 50 day moving average price is $367.69 and its 200 day moving average price is $346.71.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $8.94 EPS. On average, sell-side analysts predict that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.